Diabetes Clinical Trials in Atlanta

Showing 181-200 of 537 trials

Evaluation of Medtronic DUO Extended Set

NCT04823312

This study is a single-center, non-randomized, prospective single arm study of adult subjects with type 1 diabetes utilizing 670G insulin pump therapy with Continuous Glucose Monitoring (CGM). These subjects will be using 4 DUO Extended sets that will serve as an exploratory pilot study to assess the 7-day survival of the Duo Extended set.

Diabetes Mellitus, Type 1

Atlanta Diabetes Associates20 participantsStarted Mar 2021

Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

NCT04020822

The purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with insulin requiring diabetes,18-75 years of age.

Type 1 DiabetesType 2 Diabetes

Medtronic Diabetes19 participantsStarted Jul 2019

Aurora, Colorado, United States • Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

ACR | LAB Urine Analysis Test System Evaluation of Performance

NCT04466501

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

DiabetesHypertension

Healthy.io Ltd.375 participantsStarted Jun 2019

Atlanta, Georgia, United States • Lexington, Kentucky, United States • Garden City, New York, United States

Evaluation of Medtronic DUO Extended Set

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

ACR | LAB Urine Analysis Test System Evaluation of Performance

Diabetes Trials in Other Cities

Glargine U300 Hospital Trial

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Day and Night Closed-loop in Young People With Type 1 Diabetes

Type 1 Diabetes and the Brain in Children

Rituximab in New Onset Type 1 Diabetes

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Atlanta